| Title : Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer's Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model - Ellermann_2020_Cardiovasc.Toxicol_20_168 |
| Author(s) : Ellermann C , Coenen A , Niehues P , Leitz P , Kochhauser S , Dechering DG , Fehr M , Eckardt L , Frommeyer G |
| Ref : Cardiovasc Toxicol , 20 :168 , 2020 |
| Abstract : Ellermann_2020_Cardiovasc.Toxicol_20_168 |
| ESTHER : Ellermann_2020_Cardiovasc.Toxicol_20_168 |
| PubMedSearch : Ellermann_2020_Cardiovasc.Toxicol_20_168 |
| PubMedID: 31302839 |
Ellermann C, Coenen A, Niehues P, Leitz P, Kochhauser S, Dechering DG, Fehr M, Eckardt L, Frommeyer G (2020)
Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer's Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model
Cardiovasc Toxicol
20 :168
Ellermann C, Coenen A, Niehues P, Leitz P, Kochhauser S, Dechering DG, Fehr M, Eckardt L, Frommeyer G (2020)
Cardiovasc Toxicol
20 :168